#-supreme-cellcarta-differentiators-3-106{items-data:[{"text":"Multi-Omic Capabilities"},{"text":"Custom Assay Development "},{"text":"Global Execution "},{"text":"Biomarker Expertise "},{"text":"Collaborative Workflows"}]}#-supreme-cellcarta-overview-17-123{stats-data:[{"number":"25+ ","label":"Years of expertise "},{"number":"8 ","label":"Global facilities"},{"number":"750+ ","label":"Employees"}]}#-supreme-cellcarta-service-cards-16-106{cards-data:[{"image":"https://cellcarta.com/wp-content/uploads/2026/07/CellCarta_-19-scaled.jpg","image_alt":"","title":"Therapeutics","description":"Biomarker expertise for ADC,cell therapy,and TPD development. ","links":"Sub page title goes here | #\nSub page title goes here | #\nSub page title goes here | #\nSub page title goes here | #","link1_label":"","link1_url":"","link2_label":"Antibody-Drug Conjugates ","link2_url":"/therapeutic-areas/modalities/antibody-drug-conjugates/","link3_label":"Cell Therapy ","link4_label":"Targeted Protein Degraders ","link4_url":"/therapeutic-areas/modalities/targeted-protein-degraders/","link3_url":"/therapeutic-areas/modalities/cell-therapy/","card_link_url":"/therapeutic-areas/modalities/"},{"image":"https://cellcarta.com/wp-content/uploads/2026/07/Autoimmune-Diseases-hero-457.jpg","image_alt":"","title":"Autoimmune Diseases ","description":"Assays measuring autoreactive immune dysregulation.","links":"Sub page title goes here | #\nSub page title goes here | #\nSub page title goes here | #\nSub page title goes here | #","link1_label":"","link1_url":"","link2_label":"","link2_url":"","link3_label":"","link3_url":"","link4_label":"","link4_url":"","link5_label":"","link5_url":"","card_link_url":"/therapeutic-areas/autoimmune/"},{"image":"https://cellcarta.com/wp-content/uploads/2026/07/89-IMG_2591-1-scaled.jpg","image_alt":"","title":"Immunology","description":"Insights regarding the remodeling of immune landscape during immunotherapy intervention.","links":"Sub page title goes here | #\nSub page title goes here | #\nSub page title goes here | #\nSub page title goes here | #","link1_label":"","link1_url":"","link2_label":"","link2_url":"","card_link_url":"/therapeutic-areas/immunology/"},{"image":"https://cellcarta.com/wp-content/uploads/2026/07/Infectious-Diseases-hero-577.jpg","image_alt":"","title":"Infectious Diseases ","description":"Monitoring responses against vaccine and other infectious diseases therapeutic programs.","links":"Sub page title goes here | #\nSub page title goes here | #\nSub page title goes here | #\nSub page title goes here | #","link1_label":"","link1_url":"","link2_label":"","link2_url":"","card_link_url":"/therapeutic-areas/infectious-diseases/"},{"image":"https://cellcarta.com/wp-content/uploads/2026/07/CellCarta_-6-scaled.jpg","image_alt":"","title":"Neurosciences ","description":"Proteomic assays for CSF,plasma,and brain tissue in neurological disease programs.  ","links":"","link1_label":"","link1_url":"","card_link_url":"/therapeutic-areas/neurosciences/"},{"image":"https://cellcarta.com/wp-content/uploads/2026/06/Oncology-Hero-605.jpg","image_alt":"","title":"Oncology ","description":"Solutions spanning immune monitoring,histopathology,and mass spectrometry. ","links":"","link1_label":"","link1_url":"","card_link_url":"/therapeutic-areas/oncology/"}]}